Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Chidiac

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Infectious Diseases and Therapy|June 14, 2016
Clinical Presentation, Diagnosis, and Bacterial Epidemiology of Peritoneal Tuberculosis in Two University Hospitals in FranceZoé Cavalli, Florence Ader, Florent Valour, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2013
Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureusFlorent Valour, Judith Karsenty, Anissa Bouaziz, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2018
Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection settingLélia Abad, Virginie Tafani, Jason Tasse, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2012
Pharmacokinetic-pharmacodynamic modeling of unboosted Atazanavir in a cohort of stable HIV-infected patientsSylvain Goutelle, Thomas Baudry, Marie-Claude Gagnieu, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2018
Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial TherapyClaire Triffault-Fillit, Florent Valour, Ronan Guillo, et al.
Journal of Bone and Joint Infection|November 13, 2018
Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint InfectionZoé Cavalli, Agathe Becker, Alexie Bosch, et al.
International Journal of Chronic Diseases|October 15, 2015
Activation of Natural Killer Cells in Patients with Chronic Bone and Joint Infection due to Staphylococci Expressing or Not the Small Colony Variant PhenotypeSébastien Viel, Paul Rouzaire, Frédéric Laurent, et al.
Journal of the International AIDS Society|November 15, 2014
Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemiaJulien Saison, Tristan Ferry, Julie Demaret, et al.
Medicine|May 24, 2020
Hematogenous osteomyelitis in childhood can relapse many years later into adulthood: A retrospective multicentric cohort study in FranceAxelle Clerc, Valerie Zeller, Simon Marmor, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2018
Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophagesTristan Ferry, Fabien Boucher, Cindy Fevre, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Infectious Diseases and Therapy|June 14, 2016
Clinical Presentation, Diagnosis, and Bacterial Epidemiology of Peritoneal Tuberculosis in Two University Hospitals in FranceZoé Cavalli, Florence Ader, Florent Valour, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2013
Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureusFlorent Valour, Judith Karsenty, Anissa Bouaziz, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2018
Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection settingLélia Abad, Virginie Tafani, Jason Tasse, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2012
Pharmacokinetic-pharmacodynamic modeling of unboosted Atazanavir in a cohort of stable HIV-infected patientsSylvain Goutelle, Thomas Baudry, Marie-Claude Gagnieu, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2018
Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial TherapyClaire Triffault-Fillit, Florent Valour, Ronan Guillo, et al.
Journal of Bone and Joint Infection|November 13, 2018
Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint InfectionZoé Cavalli, Agathe Becker, Alexie Bosch, et al.
International Journal of Chronic Diseases|October 15, 2015
Activation of Natural Killer Cells in Patients with Chronic Bone and Joint Infection due to Staphylococci Expressing or Not the Small Colony Variant PhenotypeSébastien Viel, Paul Rouzaire, Frédéric Laurent, et al.
Journal of the International AIDS Society|November 15, 2014
Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemiaJulien Saison, Tristan Ferry, Julie Demaret, et al.
Medicine|May 24, 2020
Hematogenous osteomyelitis in childhood can relapse many years later into adulthood: A retrospective multicentric cohort study in FranceAxelle Clerc, Valerie Zeller, Simon Marmor, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2018
Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophagesTristan Ferry, Fabien Boucher, Cindy Fevre, et al.
Pageof 14